^○Seock-Ah Im¹, Binghe Xu², Sung-Bae Kim³, Wei-Pang Chung⁴, Yeon Hee Park⁵, Min-Hwan Kim⁶, Ling-Ming Tseng⁷, Chi-Feng Chung⁸, Chiun-Sheng Huang⁹, Jee Hyun Kim¹⁰, Joanne Wing Yan Chiu¹¹, Toshinari Yamashita¹², Wei Li¹³, Caleb Lee¹⁴, Soichiro Nishijima¹⁵, Kyohei Hamada¹⁵, Yuji Nishiyama¹⁵, Masahiro Sugihara¹⁵, Javier Cortés^16,17,18, Hiroji Iwata¹⁹ (1.Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea, 2.Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China, 3.Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, 4.Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 5.Samsung Medical Center, Seoul, Republic of Korea, 6.Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea, 7.Taipei Veterans General Hospital, Taipei, Taiwan, 8.Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan, 9.National Taiwan University Hospital, Taipei, Taiwan, 10.Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea, 11.Queen Mary Hospital, Hong Kong, China, 12.Kanagawa Cancer Center, Kanagawa, Japan, 13.The First Hospital of Jilin University, Jilin, China, 14.Daiichi Sankyo, Inc., NJ, USA, 15.Daiichi Sankyo, Co., Ltd., Tokyo, Japan, 16.International Breast Cancer Center (IBCC), Quiron Group, Barcelona, Spain, 17.Scientific Department, Medica Scientia Innovation Research (MedSIR), Valencia, Spain, 18.Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, 19.Aichi Cancer Center Hospital, Aichi, Japan)

^○Toshimi Takano^1,2, Javier Cortes^3,4, David W. Cescon⁵, Seock-Ah Im⁶, Mastura Md Yusof⁷, Hiroji Iwata⁸, Norikazu Masuda⁹, Chiun-Sheng Huang¹⁰, Chi-Feng Chung¹¹, Koichiro Tsugawa¹², Yeon Hee Park¹³, Koji Matsumoto¹⁴, Kenichi Inoue¹⁵, Ava Kwong¹⁶, Sherene Loi¹⁷, Wei Fu¹⁸, Wilbur Pan¹⁸, Valia Karantza¹⁸, Hope S. Rugo¹⁹, Peter Schmid²⁰ (1.The Cancer Institute Hospital of JFCR, Tokyo, Japan, 2.Toranomon Hospital, Tokyo, Japan, 3.International Breast Cancer Center (IBCC), Quiron Group, Madrid and Barcelona, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain, 4.Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain, 5.Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada, 6.Seoul National University Hospital, Seoul, Republic of Korea, 7.Cancer Center at Pantai Hospital, Kuala Lumpur, Malaysia, 8.Aichi Cancer Center Hospital, Nagoya, Aichi, Japan, 9.Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan, 10.National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan, 11.Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan, 12.St Marianna University School of Medicine Hospital, Kawasaki, Japan, 13.Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 14.Hyogo Cancer Center, Akashi, Hyogo, Japan, 15.Saitama Cancer Center, Saitama, Japan, 16.Queen Mary and Tung Wah Hospital and The University of Hong Kong-ShenZhen Hospital, China, 17.Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Parkville, Melbourne, VIC, Australia, 18.Merck & Co., Inc., Kenilworth, NJ, USA, 19.University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA, 20.Barts Cancer Institute, Centre for Experimental Cancer Medicine, London, UK)

^○高橋 將人¹, Cortés Javier², Dent Rebecca³, Pusztai Lajos⁴, McArthur Heather⁵, Kümmel Sherko⁶, Denkert Carsten⁷, Park Yeon Hee⁸, Im Seock-Ah⁹, Ahn Jin-Hee¹⁰, 向井 博文¹¹, Huang Chiun-Sheng¹², Chen Shin-Cheh¹³, Kim Min Hwan¹⁴, Jia Liyi¹⁵, Li Xin Tong¹⁵, Tryfonidis Konstantinos¹⁵, Karantza Vassiliki¹⁵, 岩田 広治¹⁶, Schmid Peter¹⁷ (1.国立病院機構北海道がんセンター 乳腺外科, 2.Oncology Department, IOB Institute of Oncology, Quironsalud Group, Madrid & Barcelona and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, 3.National Cancer Center Singapore, Duke-NUS Medical School, Singapore, 4.Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA, 5.UT Southwestern Medical Center, Dallas, TX, USA, 6.Breast Unit, Kliniken Essen-Mitte Evang, Huyssens-Stiftung, Essen, Germany, 7.Institute of Pathology, Philipps University Marburg, Marburg, Germany, 8.Hematology-Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 9.Seoul National University Hospital, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea, 10.Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, 11.国立がん研究センター東病院 腫瘍内科, 12.National Taiwan University Hospital, Taipei, Taiwan, 13.Chang Gung University Medical College, Taipei, Taiwan, 14.Yonsei University College of Medicine, Seoul, South Korea, 15.Merck & Co., Inc., Kenilworth, NJ, USA, 16.愛知県がんセンター病院 乳腺科部, 17.Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK)

^○松本 光史¹, 西川 忠暁², 平川 晃弘³, 川崎 真美子⁴, 都祭 紗和子⁴, 長坂 優佳里⁴, 中村 健一⁴, 長谷川 幸清⁵, 森 正彦⁶, 平嶋 泰之⁷, 竹原 和宏⁸, 有吉 和也⁹, 加藤 友康¹⁰, 柳下 薫寛¹¹, 濱田 哲暢¹¹, 吉田 裕¹², 米盛 勧² (1.兵庫県立がんセンター, 2.国立がん研究センター中央病院 腫瘍内科, 3.東京医科歯科大学 臨床統計学, 4.国立がん研究センター中央病院 臨床試験支援室, 5.埼玉医科大学国際医療センター 婦人科腫瘍科, 6.愛知県がんセンター病院 婦人科部, 7.静岡県立静岡がんセンター 婦人科, 8.独立行政法人国立病院機構四国がんセンター 婦人科, 9.独立行政法人国立病院機構九州がんセンター 婦人科, 10.国立がん研究センター中央病院 婦人腫瘍科, 11.国立がん研究センター研究所 分子薬理学分野, 12.国立がん研究センター中央病院 病理診断科)